96
Participants
Start Date
April 1, 2025
Primary Completion Date
January 1, 2028
Study Completion Date
January 1, 2031
Corneal Donor Tissue with Cross Linking
Participants are transplanted with corneal donor tissue that has been treated with 0.1% riboflavin (Vitamin B2) and 20% dextran (Photrexa® Viscous \& Photrexa®) with UV light treatment.
Corneal Donor Tissue without Cross Linking
Participants are transplanted with corneal donor tissue that has not been treated with the UV light and the 0.1% riboflavin (Vitamin B2) and 20% dextran (Photrexa® Viscous \& Photrexa®) without UV light treatment, this is the control group.
NOT_YET_RECRUITING
Wake Forest Baptist Eye Center, Bermuda Run
NOT_YET_RECRUITING
Duke University - Duke Eye Center, Durham
RECRUITING
University of Miami - Bascom Palmer Eye Institute, Miami
RECRUITING
Cincinnati Eye Institute, Cincinnati
RECRUITING
Price Vision Group, Indianapolis
NOT_YET_RECRUITING
University of Michigan - Kellogg Eye Center, Ann Arbor
NOT_YET_RECRUITING
The University of California Los Angeles - Doris Stein Eye Research Center, Los Angeles
NOT_YET_RECRUITING
University of California Irvine - Gavin Herbert Eye Institute, Irvine
NOT_YET_RECRUITING
University of California San Francisco - Wayne and Gladys Valley Center for Vision, San Francisco
RECRUITING
Massachusetts Eye and Ear, Boston
Massachusetts Eye and Ear Infirmary
OTHER